KKR Sinks Its Teeth Into Henry Schein

KKR builds stake in Henry Schein, reaches deal to add board seats
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday.
KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds affiliated with KKR & Co.
Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance
Henry Schein announces strategic investment by KKR, board changes, and provides preliminary unaudited financial results and 2025 financial guidance.
KKR builds stake in Henry Schein, agrees deal for board seats, WSJ reports
Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to improve its operations, the Wall Street Journal reported on Wednesday citing people familiar with the matter.
Strategic Investment and Growth Potential Drive Buy Rating for Henry Schein Despite Underwhelming Guidance
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from
Henry Schein gets $250 million investment from private equity firm KKR
Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...
Q1 EPS Estimates for Henry Schein Reduced by Analyst
Analysts at Barrington Research cut their Q1 2025 earnings estimates for shares of Henry Schein in a research report issued ...
Exclusive: Activist Ananym plans to launch proxy fight at Henry Schein, sources say
Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein ...
Hold Rating on Henry Schein Amid KKR Investment and Market Uncertainties
In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...
Barrington Research Issues Positive Forecast for Henry Schein (NASDAQ:HSIC) Stock Price
Henry Schein (NASDAQ:HSIC – Free Report) had its price objective hoisted by Barrington Research from $82.00 to $90.00 in a research note published on Thursday,Benzinga reports. They currently have an ...
Henry Schein Inc. stock outperforms competitors on strong trading day
Shares of Henry Schein Inc. advanced 4.95% to $79.87 Wednesday, on what proved to be an all-around poor trading session for ...
MassDevice4d
Henry Schein gets a major private equity investment
Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...
Henry Schein price target raised to $78 from $75 at Mizuho
Mizuho analyst Steven Valiquette raised the firm’s price target on Henry Schein (HSIC) to $78 from $75 and keeps a Neutral rating on the ...